GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Inventory-to-Revenue

Halberd (Halberd) Inventory-to-Revenue : 0.00 (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Halberd's Average Total Inventories for the quarter that ended in Jul. 2023 was $0.00 Mil. Halberd's Revenue for the six months ended in Jul. 2023 was $0.00 Mil. Halberd's Inventory-to-Revenue for the quarter that ended in Jul. 2023 was 0.00.

Halberd's Inventory-to-Revenue for the quarter that ended in Jul. 2023 stayed the same from Jul. 2022 (0.00) to Jul. 2022 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Halberd's Days Inventory for the six months ended in Jul. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Halberd Inventory-to-Revenue Historical Data

The historical data trend for Halberd's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Inventory-to-Revenue Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Inventory-to-Revenue
- - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Inventory-to-Revenue - - -

Competitive Comparison of Halberd's Inventory-to-Revenue

For the Biotechnology subindustry, Halberd's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Halberd's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Halberd's Inventory-to-Revenue falls into.



Halberd Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Halberd's Inventory-to-Revenue for the fiscal year that ended in Jul. 2023 is calculated as

Inventory-to-Revenue (A: Jul. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Jul. 2022 ) + Total Inventories (A: Jul. 2023 )) / count ) / Revenue (A: Jul. 2023 )
=( (0 + 0) / 1 ) / 0.003
=0 / 0.003
=0.00

Halberd's Inventory-to-Revenue for the quarter that ended in Jul. 2023 is calculated as

Inventory-to-Revenue (Q: Jul. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jul. 2022 ) + Total Inventories (Q: Jul. 2023 )) / count ) / Revenue (Q: Jul. 2023 )
=( (0 + 0) / 1 ) / 0.003
=0 / 0.003
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd  (OTCPK:HALB) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Halberd's Days Inventory for the six months ended in Jul. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Jul. 2023 )/Cost of Goods Sold (Q: Jul. 2023 )*Days in Period
=0/0.002*365 / 2
=0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Halberd's Inventory Turnover for the quarter that ended in Jul. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jul. 2023 ) / Average Total Inventories (Q: Jul. 2023 )
=0.002 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Halberd's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236